Jose Luis Poveda-Andres
Overview
Explore the profile of Jose Luis Poveda-Andres including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
142
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review
Ballesta-Lopez O, Gil-Candel M, Centelles-Oria M, Megias-Vericat J, Solana-Altabella A, Ribes-Artero H, et al.
Int J Mol Sci
. 2025 Feb;
26(4).
PMID: 40004223
Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders influenced by microbial, environmental, genetic, and immune factors. The introduction of biological agents has transformed IBD therapy, improving symptoms, reducing complications, and...
2.
Chovi-Trull M, Ballesta-Lopez O, Navarro Buendia G, Sivera-Mascaro R, Albert-Mari A, Ruiz Caldes M, et al.
Eur J Hosp Pharm
. 2024 Aug;
PMID: 39174292
A 53-year-old male with recovering alcohol dependency, diagnosed with bipolar disorder and recurrent episodes of diverticulitis, came to the emergency department with disorientation and confusion after 3 days of treatment...
3.
Montoro-Ronsano J, Poveda-Andres J, Romero-Garrido J, Garcia-Barcenilla S, Gonzalez-Alvarez I, Nunez-Vazquez R, et al.
Farm Hosp
. 2023 May;
47(3):T100-T105.
PMID: 37150664
Objective: Define consensus recommendations to improve care coordination between Hospital Pharmacy, Hematology and Nursing, inter- and intra-center, in the care of hemophilia patients. Method: Recommendations for the improvement of care...
4.
Zozaya N, Caballero T, Gonzalez-Quevedo T, Setien P, Gonzalez M, Jodar R, et al.
Glob Reg Health Technol Assess
. 2023 Jan;
9:14-21.
PMID: 36628319
Introduction: Hereditary angioedema (HAE) is a rare genetic disease that impairs quality of life and could be life-threatening. The aim of this study was to apply a multicriteria decision analysis...
5.
Solana-Altabella A, Monte-Boquet E, Montero M, Perez-Huertas P, Cuellar-Monreal M, Salavert M, et al.
Medicine (Baltimore)
. 2023 Jan;
101(49):e32208.
PMID: 36626459
To evaluate the reasons for changing to monotherapy with protease inhibitors, together with the proportion and reasons for the interruption to treatment, in patients who have been treated at some...
6.
Montoro-Ronsano J, Poveda-Andres J, Romero-Garrido J, Lopez-Chicheri Barrena B, Vella V
Farm Hosp
. 2022 Oct;
46(3):109-115.
PMID: 36183203
Objective: To identify and promote initiatives aimed at improving the management by hospital pharmacists of patients with congenital coagulopathies in the Spanish healthcare context. Method: A series of initiatives to...
7.
Zozaya N, Arrizubieta Basterrechea M, Bollo E, Castellvi I, Espin J, Ortego N, et al.
Int J Technol Assess Health Care
. 2022 Aug;
38(1):e64.
PMID: 35912833
Objectives: Our aim was to assess the value of nintedanib for non-idiopathic progressive fibrosing interstitial lung disease (non-IPF PF-ILD) and systemic sclerosis-associated ILD (SSc-ILD) in the Spanish context, using a...
8.
Solana-Altabella A, Megias-Vericat J, Ballesta-Lopez O, Boluda B, Cano I, Acuna-Cruz E, et al.
Cancers (Basel)
. 2022 Apr;
14(8).
PMID: 35454828
Background: Information regarding the impact on healthcare systems of secondary acute myeloid leukemia (sAML) is scarce. Methods: A retrospective review of medical charts identified patients aged 60-75 years with sAML...
9.
Megias-Vericat J, Bonanad-Boix S, Marques-Minana M, Poveda-Andres J
Farm Hosp
. 2022 Apr;
45(7):94-101.
PMID: 35379115
Objective: The management of surgeries in patients with hemophilia is complex and requires adequate clotting factor adjustment to avoid bleeding complications and excessive factor consumption. The aim of this systematic ...
10.
Ballesta-Lopez O, Centelles-Oria M, Marques-Minana M, Megias-Vericat J, Poveda-Andres J
Farm Hosp
. 2022 Apr;
45(7):56-63.
PMID: 35379111
Objective: The rise in the development of monoclonal antibodies has brought about a revolution in the pharmacotherapy of inflammatory bowel disease (Crohn's disease and ulcerative colitis). Systematic plasma concentrations monitoring...